Announce Date | 05/07/2025 |
EPS Normalized Actual | $1.81 (Beat by $0.54) |
EPS GAAP Actual | $1.81 (Beat by $0.54) |
Revenue Actual | $13.542B |
Revenue Surprise | Beat by $13542M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.30442 |
EPS GAAP Estimate | $2.30442 |
Revenue Estimate | $15.1823795B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 9.28522 | 8.33 | 8.67381 | 9.9133 | 2 |
Dec 2026 | 10.3554 | 7.47 | 9.89628 | 11.40704 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 4.36 | 4.36 | 13.542B | -10.28% | 13542M |
FQ3 2024 (Sep 2024) | 0 | 0 | 12.908B | -10.22% | 12908M |
FQ2 2024 (Jun 2024) | 0.49 | 0.49 | 13.241B | -13.65% | 13241M |
FQ1 2024 (Mar 2024) | 1.7 | 1.7 | 13.417B | -14.24% | 13417M |
FQ4 2023 (Dec 2023) | 4.19 | 4.19 | 14.934B | -11.56% | 14934M |
FQ3 2023 (Sep 2023) | 2.5 | 2.5 | 14.227B | -17.8% | 14227M |
FQ2 2023 (Jun 2023) | 4.13 | 4.13 | 15.049B | -19.16% | 15049M |
FQ1 2023 (Mar 2023) | 4.21 | 4.21 | 15.328B | 100% | 15328M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
2.30442
Consensus Revenue Estimates
15.1823795B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 1 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 1 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 1 |
FQ4 2026 (Oct 2026) | 2.46437 | -- | 2.26718 | 2.79389 | 3 |
FQ3 2026 (Jul 2026) | 2.45391 | -- | 2.25756 | 2.78203 | 3 |
FQ2 2026 (Jun 2026) | 2.45391 | -- | 2.23452 | 2.79259 | 1 |
FQ1 2026 (Mar 2026) | 2.44354 | -- | 2.22507 | 2.78079 | 1 |
FQ4 2025 (Oct 2025) | 2.29036 | -90.36 | 2.1071 | 2.59661 | 3 |
FQ3 2025 (Jul 2025) | 2.16909 | -- | 1.99553 | 2.45913 | 3 |
FQ2 2025 (Jun 2025) | 2.30442 | 78.74 | 2.09839 | 2.62247 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 21.92B | -- | 21.57B | 22.62B | 2 |
FQ2 2027 (Jun 2027) | 22.28B | -- | 21.93B | 23B | 2 |
FQ1 2027 (Mar 2027) | 21.34B | -- | 21B | 22.03B | 2 |
FQ4 2026 (Oct 2026) | 16.66B | -- | 15.64B | 18.38B | 2 |
FQ3 2026 (Jul 2026) | 16.55B | -- | 15.53B | 18.25B | 2 |
FQ2 2026 (Jun 2026) | 16.55B | -- | 15.41B | 18.3B | 1 |
FQ1 2026 (Mar 2026) | 16.43B | -- | 15.3B | 18.18B | 1 |
FQ4 2025 (Oct 2025) | 15.38B | 11.96 | 14.43B | 16.96B | 1 |
FQ3 2025 (Jul 2025) | 15.18B | 14.98 | 14.25B | 16.74B | 1 |
FQ2 2025 (Jun 2025) | 15.18B | 12.79 | 14.14B | 16.79B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 4.36 | 4.36 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 0.49 | 0.49 | 100% | |
FQ1 2024 (Mar 2024) | 1.7 | 1.7 | 100% | |
FQ4 2023 (Dec 2023) | 4.19 | 4.19 | 100% | |
FQ3 2023 (Sep 2023) | 2.5 | 2.5 | 100% | |
FQ2 2023 (Jun 2023) | 4.13 | 4.13 | 100% | |
FQ1 2023 (Mar 2023) | 4.21 | 4.21 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $13.54B | $13542M | 100% |
FQ3 2024 (Sep 2024) | $0B | $12.91B | $12908M | 100% |
FQ2 2024 (Jun 2024) | $0B | $13.24B | $13241M | 100% |
FQ1 2024 (Mar 2024) | $0B | $13.42B | $13417M | 100% |
FQ4 2023 (Dec 2023) | $0B | $14.93B | $14934M | 100% |
FQ3 2023 (Sep 2023) | $0B | $14.23B | $14227M | 100% |
FQ2 2023 (Jun 2023) | $0B | $15.05B | $15049M | 100% |
FQ1 2023 (Mar 2023) | $0B | $15.33B | $15328M | 100% |